Oncorus, Inc. ONCR
0.13 USD 0.00 (+0.00%)
Dec 29, 2023, 2:55 PM EST
0.125 Day range 0.20
0.01 52-week range 0.47
News
benzinga.com Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 209.5% to $2.29 after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak…
investorplace.com Why Is Oncorus (ONCR) Stock Down 27% Today? Oncorus (NASDAQ: ONCR ) stock is taking a beating on Monday after revealing plans for an upcoming special shareholder meeting. According to a filing with the Securities and Exchange Commission (SEC),…
zacks.com Oncorus (ONCR) Dips 37% on Layoff Plan & Bankruptcy Threat Oncorus (ONCR) decides to lay off nearly all of its workforce since it is facing challenges in raising additional capital. This lay off is expected to be completed by August 2023.
benzinga.com Stocks That Hit 52-Week Lows On Monday Monday's session saw 41 companies set new 52-week lows.- benzinga.com Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.
benzinga.com Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving Premarket Gainers QualTek Services Inc. (NASDAQ: QTEK) shares rose 206.7% to $0.2350 in pre-market trading after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter…
benzinga.com Stocks That Hit 52-Week Lows On Thursday Thursday's session saw 329 companies set new 52-week lows.
globenewswire.com Oncorus to Participate in Upcoming Investor Conferences ANDOVER, Mass., Nov. 23, 2022 (GLOBE NEWSWIRE) -- Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today…
benzinga.com Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.
zacks.com Oncorus, Inc. (ONCR) Moves to Buy: Rationale Behind the Upgrade Oncorus, Inc. (ONCR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 120 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 413 companies reached new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday morning, 446 companies hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 200 companies hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's session, 78 companies made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday Monday saw 825 companies set new 52-week lows.
globenewswire.com Oncorus to Present at Chardan's 6th Annual Genetic Medicines Conference ANDOVER, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today…
benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 1076 companies hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 340 stocks hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 507 stocks hit new 52-week lows.
globenewswire.com Oncorus to Present at the H.C. Wainwright 24th Annual Global Investment Conference CAMBRIDGE, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today…
zacks.com Here's Why Oncorus, Inc. (ONCR) Looks Ripe for Bottom Fishing After losing some value lately, a hammer chart pattern has been formed for Oncorus, Inc. (ONCR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate…- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2022 Upgrades
- benzinga.com 79 Biggest Movers From Yesterday Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying…
globenewswire.com Oncorus to Present at the Jefferies Global Healthcare Conference CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today…
globenewswire.com Oncorus to Present at the H.C. Wainwright Global Investment Conference CAMBRIDGE, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today…- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 1043 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 236 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 160 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 242 companies hit new 52-week lows.
globenewswire.com Oncorus to Present at the Maxim Group 2022 Virtual Growth Conference CAMBRIDGE, Mass., March 21, 2022 (GLOBE NEWSWIRE) -- Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today…- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 671 companies achieved new lows for the year.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 313 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 147 companies achieved new lows for the year.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's session, 291 companies made new 52-week lows. Also check out this: Insiders Buying These 4 Penny Stocks
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 89 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 71 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday's morning trading, 152 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's morning trading, 400 companies set new 52-week lows.
globenewswire.com Oncorus to Present at the H.C. Wainwright BioConnect Virtual Conference CAMBRIDGE, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Oncorus, Inc. (NASDAQ: ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today…
globenewswire.com Oncorus to Present at the Jefferies London Healthcare Conference CAMBRIDGE, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today…
benzinga.com Why Did Oncorus Shares Slump To 52-Week Low Today? Oncorus Inc (NASDAQ: ONCR) shares slumped after the company reported initial data for its investigational cancer therapy ONCR-177 from a Phase 1 trial in heavily pretreated patients with advanced,…
fool.com Why Oncorus Stock Is Crashing Today The company announced initial data from a phase 1 study.
benzinga.com Oncorus, Gaeta Therapeutics Ink Cancer Candidate Licensing Agreement Oncorus Inc (NASDAQ: ONCR) has signed an exclusive licensing agreement with Gaeta Therapeutics Ltd, related to the use of locally delivered Interleukin-12 (IL-12) via oncolytic viral expression in…
zacks.com Wall Street Analysts Predict a 201% Upside in Oncorus, Inc. (ONCR): Here's What You Should Know The average of price targets set by Wall Street analysts indicates a potential upside of 200.7% in Oncorus, Inc. (ONCR). While the effectiveness of this highly sought-after metric is questionable,…- benzinga.com Stocks That Hit 52-Week Lows On Thursday Thursday morning, 173 companies reached new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday Wednesday morning, 136 companies reached new 52-week lows.
- benzinga.com 78 Biggest Movers From Friday Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering.
seekingalpha.com Oncorus: Shares Look Cheap As First Oncolytic Viral Therapy Enters Clinic Oncorus shares have been in steady decline since nearly doubling in value less than six months after the company's October 2020 IPO. Current trading price of $13 is slightly under the $15 IPO price,…
globenewswire.com Oncorus Appoints Eric Rubin, M.D. to its Board of Directors -- Renowned academic and industry leader brings deep expertise in oncology translational research and drug development, including pioneering work at Merck on KEYTRUDA® (pembrolizumab) -- CAMBRIDGE,…